help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, W. P.
Right arrow Articles by Brodows, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, W. P.
Right arrow Articles by Brodows, R. G.

Journal of Clinical Endocrinology & Metabolism, Vol 57, 1102-1106, Copyright © 1983 by Endocrine Society

ARTICLES

Aspirin causes tissue insensitivity to insulin in normal man

WP Newman and RG Brodows

The effect of aspirin on glucose and insulin metabolism was examined with the hyperglycemic clamp technique in 8 normal volunteers. When the plasma glucose concentration was acutely raised and maintained at 125 mg/dl above the basal level after treatment with aspirin (3 g daily for 3 days), acute (0-10 min) and sustained (20-120 min) insulin release were 70% and 45% greater than before treatment. Despite the increased plasma insulin level, the glucose infusion rate remained unchanged (8 +/- 0.9 to 9.1 +/- 1.2 mg/kg X min). Consequently, the ratio of the glucose infusion rate to the plasma insulin level, an index of tissue sensitivity to endogenous insulin, decreased by 30%, indicative of impaired insulin action. Aspirin did not alter fasting levels of FFA. When ibuprofen, another prostaglandin synthesis inhibitor, was given to 10 normal volunteers, only an effect on acute insulin release could be demonstrated. These results demonstrate that aspirin not only enhances beta-cell sensitivity to glucose, but also impairs glucose metabolism in insulin-sensitive tissues. It is not clear whether these effects are related to aspirin's ability to inhibit prostaglandin synthesis.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, A. Lopez-Bermejo, A.-B. Ropero, S. Piquer, A. Nadal, J. Bassols, R. Casamitjana, R. Gomis, E. Arnaiz, I. Perez, et al.
Salicylates Increase Insulin Secretion in Healthy Obese Subjects
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2523 - 2530.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. Zu, H. Jiang, J. He, C. Xu, S. Pu, M. Liu, and G. Xu
Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-{alpha} in Primary Rat Adipocytes
Mol. Pharmacol., January 1, 2008; 73(1): 215 - 223.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Mohlig, M. Freudenberg, T. Bobbert, M. Ristow, H. Rochlitz, M. O. Weickert, A. F. H. Pfeiffer, and J. Spranger
Acetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 964 - 967.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society